Literature DB >> 12973746

Glutamatergic systems in Alzheimer's disease.

Paul T Francis1.   

Abstract

Glutamate is the major transmitter of the brain and is involved in all aspects of cognitive function since it is the transmitter of cortical and hippocampal pyramidal neurones. Furthermore, glutamate and glutamate receptors are involved in long-term potentiation, a process believed to underlie learning and memory. Histological studies indicate loss of pyramidal neurones and their synapses in Alzheimer's disease (AD), this together with biochemical evidence suggests presynaptic (and postsynaptic) glutamatergic hypoactivity. This represents a 'double blow' as the activity of glutamatergic neurones is heavily influenced by the cholinergic system, which is also dysfunctional in AD. The clinical relevance of these changes is emphasised because glutamatergic and cholinergic dysfunction are strong correlates of cognitive decline in AD. The mechanism by which glutamatergic (and cholinergic) cells die is likely to be a combination of necrosis and apoptosis caused by a range of factors which include tangle formation and the effects of too much and too little glutamatergic neurotransmission. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12973746     DOI: 10.1002/gps.934

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  51 in total

Review 1.  Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.

Authors:  Daniel C Mathews; Ioline D Henter; Carlos A Zarate
Journal:  Drugs       Date:  2012-07-09       Impact factor: 9.546

Review 2.  Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.

Authors:  Wojciech Danysz; Chris G Parsons
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction.

Authors:  Latha Devi; Badanavalu M Prabhu; Domenico F Galati; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Neurosci       Date:  2006-08-30       Impact factor: 6.167

Review 4.  Heptaspanning membrane receptors and cytoskeletal/scaffolding proteins: focus on adenosine, dopamine, and metabotropic glutamate receptor function.

Authors:  Francisco Ciruela; Laia Canela; Javier Burgueño; Ana Soriguera; Nuria Cabello; Enric I Canela; Vicent Casadó; Antonio Cortés; Josefa Mallol; Amina S Woods; Sergi Ferré; Carmen Lluis; Rafael Franco
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  Synaptic protein expression is regulated by a pro-oxidant diet in APPxPS1 mice.

Authors:  Martin Broadstock; Rikke Lewinsky; Emma L Jones; Cathy Mitchelmore; David R Howlett; Paul T Francis
Journal:  J Neural Transm (Vienna)       Date:  2011-11-05       Impact factor: 3.575

6.  Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy.

Authors:  Shelli R Kesler; Christa Watson; Della Koovakkattu; Clement Lee; Ruth O'Hara; Misty L Mahaffey; Jeffrey S Wefel
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

7.  Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate.

Authors:  Xinkun Wang; Xiaodong Bao; Ranu Pal; Abdulbaki Agbas; Elias K Michaelis
Journal:  BMC Genomics       Date:  2010-06-07       Impact factor: 3.969

8.  Hippocampal glutamate level and glutamate aspartate transporter (GLAST) are up-regulated in senior rat associated with isoflurane-induced spatial learning/memory impairment.

Authors:  Xiangdong Qu; Chengshi Xu; Hui Wang; Jie Xu; Weiran Liu; Yun Wang; Xingyuan Jia; Zhongcong Xie; Zhipeng Xu; Chao Ji; Anshi Wu; Yun Yue
Journal:  Neurochem Res       Date:  2012-10-16       Impact factor: 3.996

Review 9.  Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.

Authors:  Paul T Francis
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

10.  Imaging of glutamate neurotransmitter alterations in Alzheimer's disease.

Authors:  Mohammad Haris; Kavindra Nath; Kejia Cai; Anup Singh; Rachelle Crescenzi; Feliks Kogan; Gaurav Verma; Sanjana Reddy; Hari Hariharan; Elias R Melhem; Ravinder Reddy
Journal:  NMR Biomed       Date:  2012-10-09       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.